CIK 0001022079
- Large accelerated filer
QUEST DIAGNOSTICS INC
Sign in to watch- Ticker
- DGX
- Exchange
- NYSE
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 161387862
- Phone
- +1 973-520-2700
- Business address
- 500 PLAZA DRIVE, SECAUCUS, NJ, 07094
- Former names
- CORNING CLINICAL LABORATORIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $19,794,069
- in 6 filings, $19.8M under 10b5-1 plans
Net −$19,794,069. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- PREVOZNIK MICHAEL E −$5.5M SVP & General Counsel sold 38% of stake
- Doherty Catherine T. −$5.5M Executive Vice President sold 24% of stake
- Deppe Michael J −$3.1M SVP, Corp. Controller & CAO sold 25% of stake
- Plewman Patrick −$3.0M SVP for Diagnostic Services sold 44% of stake
- Davis J. E. −$2.4M CEO and President sold 8% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-02-17 | Mendez Manuel O. SVP & Chief Commercial Officer | Grant or award | +4,926 | 29,045 | ||
| 2021-02-17 | Mendez Manuel O. SVP & Chief Commercial Officer | Grant or award · Non-Qualifed Stock Option (right to buy) | +27,633 | 27,633 | ||
| 2021-02-17 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Grant or award | +21,551 | 259,298 | ||
| 2021-02-17 | RUSCKOWSKI STEPHEN H Chairman, CEO and President | Grant or award · Non-Qualifed Stock Option (right to buy) | +120,901 | 120,901 | ||
| 2021-02-17 | PREVOZNIK MICHAEL E SVP & General Counsel | Grant or award | +3,202 | 43,289 | ||
| 2021-02-17 | PREVOZNIK MICHAEL E SVP & General Counsel | Grant or award · Non-Qualifed Stock Option (right to buy) | +17,958 | 17,958 | ||
| 2021-02-17 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Grant or award | +715 | 25,863 | ||
| 2021-02-17 | DEPPE MICHAEL J VP, Corp. Controller & CAO | Grant or award · Non-Qualifed Stock Option (right to buy) | +4,003 | 4,003 | ||
| 2021-02-17 | GUINAN MARK Executive Vice President & CFO | Grant or award | +5,665 | 79,244 | ||
| 2021-02-17 | GUINAN MARK Executive Vice President & CFO | Grant or award · Non-Qualifed Stock Option (right to buy) | +31,774 | 31,774 | ||
| 2021-02-17 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Grant or award | +3,941 | 72,352 | ||
| 2021-02-17 | Doherty Catherine T. SVP, Group Exec. Clin. Fran. | Grant or award · Non-Qualifed Stock Option (right to buy) | +22,105 | 22,105 | ||
| 2021-02-17 | Davis J. E. EVP, General Diagnostics | Grant or award | +5,665 | 43,751 | ||
| 2021-02-17 | Davis J. E. EVP, General Diagnostics | Grant or award · Non-Qualifed Stock Option (right to buy) | +31,774 | 31,774 | ||
| 2021-02-17 | EGLINTON MANNER CARRIE SVP, Advanced Diagnostics | Grant or award | +4,926 | 24,841 | ||
| 2021-02-17 | EGLINTON MANNER CARRIE SVP, Advanced Diagnostics | Grant or award · Non-Qualifed Stock Option (right to buy) | +27,633 | 27,633 | ||
| 2021-01-04 | RING TIMOTHY M Director | Grant or award · Phantom Stock Units | +264 | $119.93 | $32K | 10,313 |
| 2021-01-04 | EGLINTON MANNER CARRIE SVP, Advanced Diagnostics | Shares withheld for taxes | −2,640 | $119.00 | $314K | 19,896 |
| 2020-12-24 | GUINAN MARK Executive Vice President & CFO | Option exercise | +81,756 | $66.51 | $5.4M | 155,335 |
| 2020-12-24 | GUINAN MARK Executive Vice President & CFO | Sale | −59,193 | $120.06 | $7.1M | 96,142 |
Page 38 of 42 · 826 trades